Line 19: | Line 19: | ||
<p><span style="color: #f2f0f0;">Our work this year evolved with the development of the mGEM project. To aid in the Wet Lab and Dry Lab’s understanding of theory, we wrote a paper about the historical development and current applications of next-generation sequencing (NGS) technology. In collaboration with the Wet Lab team, we shaped the direction of the mGEM project towards amyloid-beta aggregation by discussing how the amyloid-beta hypothesis is viewed in scientific communities and how constantly shifting research affects the public’s response to Alzheimer’s Disease (AD). We consequently interviewed professionals in the research, clinical, and public fields on how Alzheimer’s Disease research affects public perceptions and clinical approaches towards it. </p> | <p><span style="color: #f2f0f0;">Our work this year evolved with the development of the mGEM project. To aid in the Wet Lab and Dry Lab’s understanding of theory, we wrote a paper about the historical development and current applications of next-generation sequencing (NGS) technology. In collaboration with the Wet Lab team, we shaped the direction of the mGEM project towards amyloid-beta aggregation by discussing how the amyloid-beta hypothesis is viewed in scientific communities and how constantly shifting research affects the public’s response to Alzheimer’s Disease (AD). We consequently interviewed professionals in the research, clinical, and public fields on how Alzheimer’s Disease research affects public perceptions and clinical approaches towards it. </p> | ||
</br></br> | </br></br> | ||
+ | |||
+ | <center> <div><video width = "75%"; poster="https://static.igem.org/mediawiki/2018/8/89/T--McMaster--Video.mp4" controls> | ||
+ | <source src="https://static.igem.org/mediawiki/2018/8/89/T--McMaster--Video.mp4#t=0.1" type='video/mp4'/> | ||
Revision as of 03:57, 18 October 2018